×
  • Category
  • Type
  • Advanced

Mozambique_Vaccination Intra-Action Review (IAR) report

India_Déploiement du vaccin contre la COVID-19 et outils numériques

Éléments à prendre en considération pour intégrer la vaccination contre la COVID-19 dans les programmes de vaccination et les soins de santé primaires pour 2022 et au-delà

IMMUNIZATION AGENDA 2030 WHY GENDER MATTERS

A guide for conducting an Expanded Programme on Immunization (EPI) Review

GUIDANCE NOTE – COVERAGE AND EQUITY ASSESSMENTS FOR IMMUNIZATION PROGRAMS

EMBEDDING A HUMAN-CENTRED DESIGN APPROACH IN SUBNATIONAL COVERAGE AND EQUITY ASSESSMENTS

A quick guide to inform understanding of gender-related barriers to immunisation: learning from research

A GUIDE FOR CONDUCTING A SITUATION ANALYSIS OF IMMUNIZATION PROGRAMME PERFORMANCE

ANALYSIS GUIDANCE 2020

Facteurs comportementaux et sociaux de la vaccination : outils et conseils pratiques pour parvenir à une adoption vaccinale élevée

Good practice statement on the use of second booster doses for COVID 19 vaccines

Annexes to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19: grading of evidence: evidence to recommendations tables, first issued 18 August 2022

Background to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19: background document to the WHO: interim recommendations for use of the Valneva vaccine VLA2001 against COVID-19

Interim recommendations for use of the Valneva VLA2001 vaccine against COVID 19: interim guidance, first issued 18 August 2022

AOP Template

AOP Guidance

NIS Guidance Annex_NIS Outline

NIS Guidance Annex_IA2030 Checklist

NIS Guidance Annex_Conducting Desk Review